Considine, Bryden
Hurwitz, Michael E.
Article History
First Online: 8 March 2019
Compliance with Ethical Standards
:
: Bryden Considine declares that he has no conflict of interest.Michael E. Hurwitz declares the following disclosures: (1) Advisory Boards/Consulting: Nektar Therapeutics, Janssen Pharmaceuticals, CRISPR Therapeutics; (2) Research: Apexigen, Astellas, AstraZeneca, Bayer, Bristol Myer Squibb, Clovis, Corvus, Eli Lilly, Endocyte, Genentech, Genmab, Innocrin, Iovance, MedImmune, Merck, Nektar Therapeutics, Novartis, Pfizer, Progenics, Roche Laboratories, Sanofi Aventis, Seattle Genetics; and (3) Other: Gamida Cell.
: This article does not contain any studies with human or animal subjects performed by any of the authors.